Financial Instruments (Tables)

9 Months Ended

Sep. 26, 2020

Notes To Financial Statements [Abstract]

Schedule of Derivative Instruments in Statement of Financial Position, Fair Value

The following table summarizes the company’s fair value of interest rate swaps (in thousands):

	Condensed Consolidated Balance Sheet Presentation	Sep 26, 2020		Dec 28, 2019
Fair value	Other assets	$	—	$	1,830
Fair value	Accrued expenses	$	15,282	$	—
Fair value	Other non-current liabilities	$	42,538	$	25,120

Schedule of Derivative Instruments, Gain (Loss) in Statement of Financial Performance

The impact on earnings from interest rate swaps was as follows (in thousands):

		Three Months Ended				Nine Months Ended
	Presentation of Gain/(loss)	Sep 26, 2020		Sep 28, 2019		Sep 26, 2020		Sep 28, 2019
Gain/(loss) recognized in accumulated other comprehensive income	Other comprehensive income	$	(1,545)	$	(7,114)	$	(44,949)	$	(37,090)
Gain/(loss) reclassified from accumulated other comprehensive income (effective portion)	Interest expense	$	(5,158)	$	403	$	(10,419)	$	1,953